UBS Reiterates a 'Buy' on Concur Technologies (CNQR): A Favorite Saas Play and Attractive M&A Target
Tweet Send to a FriendGet Alerts CNQR Hot Sheet
Price: $79.76 -0.76%
Rating Summary:
8 Buy, 10 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
8 Buy, 10 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade CNQR Now!
UBS reiterates a 'Buy' on Concur Technologies (NASDAQ: CNQR) price target raised from $66 to $70.
Analyst, Brent Thill, said, "Revenue growth of 28.1% beat 25% guide driven by upside in customer deployments (espec. SMBs) and travel transaction volume (implying healthy enterprise core). Newer growth initiatives, such as India, Japan, and migration of legacy ADP-sourced customer base achieved stronger than expected bookings. Overall, F1H12 bookings growth are running faster than FY11’s 35% pace – which bodes well for continued 25%+ revenue growth in FY13. CNQR remains one of our favorite SaaS plays, with highly predictable revenues and as an attractive M&A target."
UBS bumps FY12 EPS estimate by $0.02 to $0.87 and FY13 by $0.03 to $1.11.
For an analyst ratings summary and ratings history on Concur Technologies click here. For more ratings news on Concur Technologies click here.
Shares of Concur Technologies closed at $57.98 yesterday, with a 52 week range of $34.30-$62.60.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Brent Thill, said, "Revenue growth of 28.1% beat 25% guide driven by upside in customer deployments (espec. SMBs) and travel transaction volume (implying healthy enterprise core). Newer growth initiatives, such as India, Japan, and migration of legacy ADP-sourced customer base achieved stronger than expected bookings. Overall, F1H12 bookings growth are running faster than FY11’s 35% pace – which bodes well for continued 25%+ revenue growth in FY13. CNQR remains one of our favorite SaaS plays, with highly predictable revenues and as an attractive M&A target."
UBS bumps FY12 EPS estimate by $0.02 to $0.87 and FY13 by $0.03 to $1.11.
For an analyst ratings summary and ratings history on Concur Technologies click here. For more ratings news on Concur Technologies click here.
Shares of Concur Technologies closed at $57.98 yesterday, with a 52 week range of $34.30-$62.60.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: UBS Starts Insmed (INSM) at Buy
- Goldman Sachs Upgrades Mizuho Financial Group Inc. (MFG) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, Mergers and AcquisitionsRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
